+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Plasmid DNA CDMO Service Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 184 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6126986
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Plasmid DNA CDMO services have become a pivotal enabler for companies advancing next-generation gene and cell therapies. As the market evolves, senior decision-makers face complex choices around outsourcing, compliance, and supply chain management—all key drivers in maintaining competitive positioning and risk-aware growth strategies.

Market Snapshot: Growth and Opportunity in the Plasmid DNA CDMO Service Market

The plasmid DNA CDMO service market is experiencing rapid expansion, primarily fueled by rising demand from gene therapy, cell therapy, and nucleic acid-based segments. Current market sizing demonstrates strong year-on-year growth and a double-digit compound annual growth rate (CAGR) expected throughout the forecast period. This momentum is underpinned by surging applications in regulated pharmaceutical manufacturing, as well as an increasing number of active clinical pipelines. For biopharma executives, the focus on reliability, repeatable compliance, and scalability places plasmid DNA CDMOs at the center of supply strategies within the dynamic landscape of advanced therapeutics.

Scope & Segmentation of the Plasmid DNA CDMO Service Market

  • Service Types: Includes process development, GMP manufacturing, analytical characterization, and fill-finish capabilities, supporting a range of plasmid DNA formats.
  • End-Use Modalities: Spans direct usage in DNA vaccines and gene therapies, as well as roles as starting material for viral vector production and templates for in vitro transcription in mRNA platforms.
  • Quality Attributes: Emphasizes key benchmarks such as supercoiled content, impurity clearance, robust endotoxin control, and thorough supporting documentation across batches.
  • Client Types: Covers the needs of emerging biotechs seeking flexible and bundled solutions, and large biopharma organizations that require specialized providers for phased or staged execution.
  • Geographic Regions: Analysis captures the distinctive regulatory, compliance, and logistical settings across the Americas, EMEA (Europe, Middle East, Africa), and Asia-Pacific, each influencing project execution and partnership timelines.
  • Technology Platforms: Features evolving models—including platform manufacturing, customizable process designs, digital quality systems, and advanced analytics—to enhance raw material traceability and end-to-end process monitoring.

Key Takeaways for Senior Decision-Makers

  • Plasmid DNA CDMO providers are integral to the supply chains underpinning advanced therapies by delivering biologics-level standards and fast-turn GMP production.
  • Outsourcing strategies are shifting toward partnerships that proactively address risk, support clinical phase transitions, and offer flexibility for custom plasmid configurations.
  • Regulatory frameworks now demand advanced analytical profiling, enhanced documentation, and improved traceability for materials and process changes from initial through late-stage production.
  • Increasingly, CDMOs advise clients on sequence design, optimal host selection, and downstream modality compatibility to enhance plasmid suitability and functional yield for each indication.
  • Distinct regional practices influence sourcing decisions: Americas focus on audit readiness and supply continuity, EMEA values harmonized compliance, and Asia-Pacific accelerates clinical innovation and process deployment.
  • The competitive environment emphasizes not just manufacturing capacity, but also operational reliability, digital quality integration, and the ability to deliver across multi-site programs for resilience and program continuity.

Tariff Impact: U.S. Policies Driving Sourcing Strategies

Recent U.S. tariffs have increased cost fluctuations for key raw materials, compelling sponsors to revisit supply chain localization and risk mitigation. CDMOs are reacting by expanding dual-sourcing models, building domestic manufacturing capacity, and adopting indexed pricing structures. This evolution prompts a move from traditional per-gram pricing to total cost of ownership frameworks, making supply chain transparency and regional resilience essential considerations for senior procurement leaders.

Methodology & Data Sources

This report combines in-depth secondary research—including regulatory documents, public company disclosures, and scientific literature reviews—with direct interviews from biopharma sponsors and CDMO stakeholders. Triangulation with real-world decision factors and operational failure modes ensures actionable insights that reflect the current realities of the plasmid DNA CDMO sector.

Why This Report Matters

  • Gain clear visibility into key drivers and evolving standards shaping the plasmid DNA CDMO market, from market industrialization to modality-specific service differentiation.
  • Systematically benchmark providers’ technical and regional execution capabilities, helping prioritize the attributes most critical to your therapeutic pipeline’s needs.
  • Directly inform procurement and sourcing strategies by understanding the impact of tariffs, localization initiatives, and scaling considerations on partnership choices.

Conclusion

Achieving success in plasmid DNA CDMO services now rests on rigorous quality alignment, tariff-conscious supply resilience, and careful partner management. Early and strategic definition of process specifications and sourcing channels supports consistent compliance and operational performance as advanced therapies evolve.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Plasmid DNA CDMO Service Market, by Service Type
8.1. Analytical & QC
8.1.1. Endotoxin Testing
8.1.2. Identity Testing
8.1.3. Purity Testing
8.1.4. Sterility Testing
8.2. Downstream
8.2.1. Clarification
8.2.2. Formulation
8.2.3. Harvesting
8.2.4. Purification
8.3. Fill Finish
8.3.1. Freeze Drying
8.3.2. Vial Filling
8.4. Upstream
8.4.1. Cell Culture
8.4.2. Plasmid Construction
8.4.3. Transfection
9. Plasmid DNA CDMO Service Market, by Production Scale
9.1. Clinical
9.2. Commercial
9.3. Preclinical
10. Plasmid DNA CDMO Service Market, by Plasmid Size
10.1. Large
10.2. Medium
10.3. Small
11. Plasmid DNA CDMO Service Market, by Application
11.1. Animal Health
11.2. Cell And Gene Therapy
11.3. DNA Vaccines
11.4. Gene Therapy
11.5. Research Reagents
12. Plasmid DNA CDMO Service Market, by End User
12.1. Academic And Research Institutes
12.2. Biopharma Companies
12.3. CROs And CDMOs
13. Plasmid DNA CDMO Service Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Plasmid DNA CDMO Service Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Plasmid DNA CDMO Service Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Plasmid DNA CDMO Service Market
17. China Plasmid DNA CDMO Service Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AcuraBio LLC
18.6. AGC Biologics, Inc.
18.7. Akron Biotech LLC
18.8. Aldevron, Inc.
18.9. Bio Elpida, Inc.
18.10. Biomay AG
18.11. Catalent, Inc.
18.12. Cell and Gene Therapy Catapult
18.13. Cobra Biologics Limited
18.14. Cytovance Biologics, Inc.
18.15. Fujifilm Diosynth Biotechnologies UK Limited
18.16. GenScript Biotech Corporation
18.17. Kaneka Eurogentec S.A.
18.18. Lonza Group AG
18.19. Merck KGaA
18.20. Rentschler Biopharma SE
18.21. Richter-Helm BioLogics GmbH & Co. KG
18.22. Samsung Biologics Co., Ltd.
18.23. Sartorius AG
18.24. Synlogic, Inc.
18.25. Thermo Fisher Scientific Inc.
18.26. VGXI, Inc.
18.27. Waisman Biomanufacturing
18.28. Wuxi AppTec Co., Ltd.
List of Figures
FIGURE 1. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PLASMID DNA CDMO SERVICE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PLASMID DNA CDMO SERVICE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY PLASMID SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES PLASMID DNA CDMO SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA PLASMID DNA CDMO SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANALYTICAL & QC, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANALYTICAL & QC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANALYTICAL & QC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANALYTICAL & QC, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY ENDOTOXIN TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY ENDOTOXIN TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY ENDOTOXIN TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY IDENTITY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY IDENTITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY IDENTITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY PURITY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY PURITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY PURITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY STERILITY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY STERILITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY STERILITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY DOWNSTREAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY DOWNSTREAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY DOWNSTREAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY DOWNSTREAM, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY CLARIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY CLARIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY CLARIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY FORMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY FORMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY FORMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY HARVESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY HARVESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY HARVESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY PURIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY PURIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY PURIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY FILL FINISH, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY FILL FINISH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY FILL FINISH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY FILL FINISH, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY FREEZE DRYING, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY FREEZE DRYING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY FREEZE DRYING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY VIAL FILLING, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY VIAL FILLING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY VIAL FILLING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY UPSTREAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY UPSTREAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY UPSTREAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY UPSTREAM, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY PLASMID CONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY PLASMID CONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY PLASMID CONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY TRANSFECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY TRANSFECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY TRANSFECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY CLINICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY CLINICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY CLINICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY COMMERCIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY PRECLINICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY PRECLINICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY PLASMID SIZE, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY LARGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY LARGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY LARGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY MEDIUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY MEDIUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY MEDIUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY SMALL, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY SMALL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY SMALL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANIMAL HEALTH, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANIMAL HEALTH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANIMAL HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY CELL AND GENE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY CELL AND GENE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY CELL AND GENE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY DNA VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY DNA VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY GENE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY RESEARCH REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY RESEARCH REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY RESEARCH REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY BIOPHARMA COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY BIOPHARMA COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY BIOPHARMA COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY CROS AND CDMOS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY CROS AND CDMOS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY CROS AND CDMOS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS PLASMID DNA CDMO SERVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS PLASMID DNA CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANALYTICAL & QC, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS PLASMID DNA CDMO SERVICE MARKET SIZE, BY DOWNSTREAM, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS PLASMID DNA CDMO SERVICE MARKET SIZE, BY FILL FINISH, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS PLASMID DNA CDMO SERVICE MARKET SIZE, BY UPSTREAM, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS PLASMID DNA CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS PLASMID DNA CDMO SERVICE MARKET SIZE, BY PLASMID SIZE, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS PLASMID DNA CDMO SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS PLASMID DNA CDMO SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANALYTICAL & QC, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY DOWNSTREAM, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY FILL FINISH, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY UPSTREAM, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY PLASMID SIZE, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANALYTICAL & QC, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY DOWNSTREAM, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY FILL FINISH, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY UPSTREAM, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY PLASMID SIZE, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANALYTICAL & QC, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY DOWNSTREAM, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY FILL FINISH, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY UPSTREAM, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY PLASMID SIZE, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 145. EUROPE PLASMID DNA CDMO SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. EUROPE PLASMID DNA CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 147. EUROPE PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANALYTICAL & QC, 2018-2032 (USD MILLION)
TABLE 148. EUROPE PLASMID DNA CDMO SERVICE MARKET SIZE, BY DOWNSTREAM, 2018-2032 (USD MILLION)
TABLE 149. EUROPE PLASMID DNA CDMO SERVICE MARKET SIZE, BY FILL FINISH, 2018-2032 (USD MILLION)
TABLE 150. EUROPE PLASMID DNA CDMO SERVICE MARKET SIZE, BY UPSTREAM, 2018-2032 (USD MILLION)
TABLE 151. EUROPE PLASMID DNA CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 152. EUROPE PLASMID DNA CDMO SERVICE MARKET SIZE, BY PLASMID SIZE, 2018-2032 (USD MILLION)
TABLE 153. EUROPE PLASMID DNA CDMO SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 154. EUROPE PLASMID DNA CDMO SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST PLASMID DNA CDMO SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST PLASMID DNA CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANALYTICAL & QC, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST PLASMID DNA CDMO SERVICE MARKET SIZE, BY DOWNSTREAM, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST PLASMID DNA CDMO SERVICE MARKET SIZE, BY FILL FINISH, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST PLASMID DNA CDMO SERVICE MARKET SIZE, BY UPSTREAM, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST PLASMID DNA CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST PLASMID DNA CDMO SERVICE MARKET SIZE, BY PLASMID SIZE, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST PLASMID DNA CDMO SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST PLASMID DNA CDMO SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 165. AFRICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. AFRICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 167. AFRICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANALYTICAL & QC, 2018-2032 (USD MILLION)
TABLE 168. AFRICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY DOWNSTREAM, 2018-2032 (USD MILLION)
TABLE 169. AFRICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY FILL FINISH, 2018-2032 (USD MILLION)
TABLE 170. AFRICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY UPSTREAM, 2018-2032 (USD MILLION)
TABLE 171. AFRICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 172. AFRICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY PLASMID SIZE, 2018-2032 (USD MILLION)
TABLE 173. AFRICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 174. AFRICA PLASMID DNA CDMO SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC PLASMID DNA CDMO SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC PLASMID DNA CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANALYTICAL & QC, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC PLASMID DNA CDMO SERVICE MARKET SIZE, BY DOWNSTREAM, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC PLASMID DNA CDMO SERVICE MARKET SIZE, BY FILL FINISH, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC PLASMID DNA CDMO SERVICE MARKET SIZE, BY UPSTREAM, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC PLASMID DNA CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC PLASMID DNA CDMO SERVICE MARKET SIZE, BY PLASMID SIZE, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC PLASMID DNA CDMO SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC PLASMID DNA CDMO SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 186. ASEAN PLASMID DNA CDMO SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. ASEAN PLASMID DNA CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 188. ASEAN PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANALYTICAL & QC, 2018-2032 (USD MILLION)
TABLE 189. ASEAN PLASMID DNA CDMO SERVICE MARKET SIZE, BY DOWNSTREAM, 2018-2032 (USD MILLION)
TABLE 190. ASEAN PLASMID DNA CDMO SERVICE MARKET SIZE, BY FILL FINISH, 2018-2032 (USD MILLION)
TABLE 191. ASEAN PLASMID DNA CDMO SERVICE MARKET SIZE, BY UPSTREAM, 2018-2032 (USD MILLION)
TABLE 192. ASEAN PLASMID DNA CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 193. ASEAN PLASMID DNA CDMO SERVICE MARKET SIZE, BY PLASMID SIZE, 2018-2032 (USD MILLION)
TABLE 194. ASEAN PLASMID DNA CDMO SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 195. ASEAN PLASMID DNA CDMO SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 196. GCC PLASMID DNA CDMO SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 197. GCC PLASMID DNA CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 198. GCC PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANALYTICAL & QC, 2018-2032 (USD MILLION)
TABLE 199. GCC PLASMID DNA CDMO SERVICE MARKET SIZE, BY DOWNSTREAM, 2018-2032 (USD MILLION)
TABLE 200. GCC PLASMID DNA CDMO SERVICE MARKET SIZE, BY FILL FINISH, 2018-2032 (USD MILLION)
TABLE 201. GCC PLASMID DNA CDMO SERVICE MARKET SIZE, BY UPSTREAM, 2018-2032 (USD MILLION)
TABLE 202. GCC PLASMID DNA CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 203. GCC PLASMID DNA CDMO SERVICE MARKET SIZE, BY PLASMID SIZE, 2018-2032 (USD MILLION)
TABLE 204. GCC PLASMID DNA CDMO SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 205. GCC PLASMID DNA CDMO SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION PLASMID DNA CDMO SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION PLASMID DNA CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANALYTICAL & QC, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION PLASMID DNA CDMO SERVICE MARKET SIZE, BY DOWNSTREAM, 2018-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION PLASMID DNA CDMO SERVICE MARKET SIZE, BY FILL FINISH, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION PLASMID DNA CDMO SERVICE MARKET SIZE, BY UPSTREAM, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION PLASMID DNA CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION PLASMID DNA CDMO SERVICE MARKET SIZE, BY PLASMID SIZE, 2018-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION PLASMID DNA CDMO SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION PLASMID DNA CDMO SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. BRICS PLASMID DNA CDMO SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. BRICS PLASMID DNA CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 218. BRICS PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANALYTICAL & QC, 2018-2032 (USD MILLION)
TABLE 219. BRICS PLASMID DNA CDMO SERVICE MARKET SIZE, BY DOWNSTREAM, 2018-2032 (USD MILLION)
TABLE 220. BRICS PLASMID DNA CDMO SERVICE MARKET SIZE, BY FILL FINISH, 2018-2032 (USD MILLION)
TABLE 221. BRICS PLASMID DNA CDMO SERVICE MARKET SIZE, BY UPSTREAM, 2018-2032 (USD MILLION)
TABLE 222. BRICS PLASMID DNA CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 223. BRICS PLASMID DNA CDMO SERVICE MARKET SIZE, BY PLASMID SIZE, 2018-2032 (USD MILLION)
TABLE 224. BRICS PLASMID DNA CDMO SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 225. BRICS PLASMID DNA CDMO SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. G7 PLASMID DNA CDMO SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 227. G7 PLASMID DNA CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 228. G7 PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANALYTICAL & QC, 2018-2032 (USD MILLION)
TABLE 229. G7 PLASMID DNA CDMO SERVICE MARKET SIZE, BY DOWNSTREAM, 2018-2032 (USD MILLION)
TABLE 230. G7 PLASMID DNA CDMO SERVICE MARKET SIZE, BY FILL FINISH, 2018-2032 (USD MILLION)
TABLE 231. G7 PLASMID DNA CDMO SERVICE MARKET SIZE, BY UPSTREAM, 2018-2032 (USD MILLION)
TABLE 232. G7 PLASMID DNA CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 233. G7 PLASMID DNA CDMO SERVICE MARKET SIZE, BY PLASMID SIZE, 2018-2032 (USD MILLION)
TABLE 234. G7 PLASMID DNA CDMO SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 235. G7 PLASMID DNA CDMO SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 236. NATO PLASMID DNA CDMO SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 237. NATO PLASMID DNA CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 238. NATO PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANALYTICAL & QC, 2018-2032 (USD MILLION)
TABLE 239. NATO PLASMID DNA CDMO SERVICE MARKET SIZE, BY DOWNSTREAM, 2018-2032 (USD MILLION)
TABLE 240. NATO PLASMID DNA CDMO SERVICE MARKET SIZE, BY FILL FINISH, 2018-2032 (USD MILLION)
TABLE 241. NATO PLASMID DNA CDMO SERVICE MARKET SIZE, BY UPSTREAM, 2018-2032 (USD MILLION)
TABLE 242. NATO PLASMID DNA CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 243. NATO PLASMID DNA CDMO SERVICE MARKET SIZE, BY PLASMID SIZE, 2018-2032 (USD MILLION)
TABLE 244. NATO PLASMID DNA CDMO SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 245. NATO PLASMID DNA CDMO SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 246. GLOBAL PLASMID DNA CDMO SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. UNITED STATES PLASMID DNA CDMO SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 248. UNITED STATES PLASMID DNA CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 249. UNITED STATES PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANALYTICAL & QC, 2018-2032 (USD MILLION)
TABLE 250. UNITED STATES PLASMID DNA CDMO SERVICE MARKET SIZE, BY DOWNSTREAM, 2018-2032 (USD MILLION)
TABLE 251. UNITED STATES PLASMID DNA CDMO SERVICE MARKET SIZE, BY FILL FINISH, 2018-2032 (USD MILLION)
TABLE 252. UNITED STATES PLASMID DNA CDMO SERVICE MARKET SIZE, BY UPSTREAM, 2018-2032 (USD MILLION)
TABLE 253. UNITED STATES PLASMID DNA CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 254. UNITED STATES PLASMID DNA CDMO SERVICE MARKET SIZE, BY PLASMID SIZE, 2018-2032 (USD MILLION)
TABLE 255. UNITED STATES PLASMID DNA CDMO SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 256. UNITED STATES PLASMID DNA CDMO SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 257. CHINA PLASMID DNA CDMO SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 258. CHINA PLASMID DNA CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 259. CHINA PLASMID DNA CDMO SERVICE MARKET SIZE, BY ANALYTICAL & QC, 2018-2032 (USD MILLION)
TABLE 260. CHINA PLASMID DNA CDMO SERVICE MARKET SIZE, BY DOWNSTREAM, 2018-2032 (USD MILLION)
TABLE 261. CHINA PLASMID DNA CDMO SERVICE MARKET SIZE, BY FILL FINISH, 2018-2032 (USD MILLION)
TABLE 262. CHINA PLASMID DNA CDMO SERVICE MARKET SIZE, BY UPSTREAM, 2018-2032 (USD MILLION)
TABLE 263. CHINA PLASMID DNA CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 264. CHINA PLASMID DNA CDMO SERVICE MARKET SIZE, BY PLASMID SIZE, 2018-2032 (USD MILLION)
TABLE 265. CHINA PLASMID DNA CDMO SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 266. CHINA PLASMID DNA CDMO SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Plasmid DNA CDMO Service market report include:
  • AcuraBio LLC
  • AGC Biologics, Inc.
  • Akron Biotech LLC
  • Aldevron, Inc.
  • Bio Elpida, Inc.
  • Biomay AG
  • Catalent, Inc.
  • Cell and Gene Therapy Catapult
  • Cobra Biologics Limited
  • Cytovance Biologics, Inc.
  • Fujifilm Diosynth Biotechnologies UK Limited
  • GenScript Biotech Corporation
  • Kaneka Eurogentec S.A.
  • Lonza Group AG
  • Merck KGaA
  • Rentschler Biopharma SE
  • Richter-Helm BioLogics GmbH & Co. KG
  • Samsung Biologics Co., Ltd.
  • Sartorius AG
  • Synlogic, Inc.
  • Thermo Fisher Scientific Inc.
  • VGXI, Inc.
  • Waisman Biomanufacturing
  • Wuxi AppTec Co., Ltd.

Table Information